JDD September Issue Highlights
Below are the issue highlights for the September issue of the JDD.
Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers …
Below are the issue highlights for the September issue of the JDD.
Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers … 
The hyperproliferative epithelium of this mature psoriasis plaque is associated with increased expression of which keratin(s)?
A. K1, K10
B. K5, K14
C. K6, K16
D. K17
E. K2e
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center.
COVID-19 DERM TOPICS
COVID-19 Peer-reviewed Articles
Safely Reopening Derm Practices Video Series
JDD COVID-19 Webinar Series
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi … 
The skin findings in COVID-19 patients include a morbilliform rash, urticaria, vesicular eruptions, acral lesions (COVID toes), livedoid eruptions, and other nonspecific skin findings.
Skin findings of COVID-19 disease are similar to the cutaneous findings in other viral infections. Some of the skin findings are more commonly associated with COVID-19 infection than with other viruses sugg … 
As recent dermatology residency graduates like myself are well aware, the landscape is set – we will be taking our boards in October. Admittedly, when the ABD (American Board of Dermatology) inquired about when residents would like to take the exam, I responded – “July, please”. But as an entity that must look out for the interests of everyone while navigating the challenges of this pand …